Skip to main content
Premium Trial:

Request an Annual Quote

Enzymatics Gets ISO Certifications

NEW YORK (GenomeWeb News) – Molecular biology enzymes manufacturer Enzymatics today said that it has received ISO 13485:2003 and 9001:2000 standards certification from TÜV SÜD America.

The Beverly, Mass.-based firm makes proteins that are used for research and diagnostics purposes with a focus on nucleic acid detection technologies. It provides enzymes and buffer solutions for the Polonator, a low-cost sequencing system developed by George Church's group at Harvard Medical School and sold by the Dover unit of Danaher-Motion.

ISO 13485:2003 is a globally recognized standard that specifies requirements for a quality management system and is intended to facilitate harmonized medical device regulatory requirements for quality management systems. ISO 9001:2000 shares significant overlap with 13485:2003, while including a focus on continuous improvement and customer satisfaction, said Enzymatics.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more